openPR Logo
Press release

Lasting Relief from Acid Reflux: GERD Surgery in Los Angeles by Dr. Moein

10-29-2025 06:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

The goal of GERD surgery is to strengthen the LES and prevent stomach acid from flowing back into the esophagus. Common surgical options include Nissen fundoplication, the LINX magnetic device, or Transoral Incisionless Fundoplication (TIF), a minimally i

The goal of GERD surgery is to strengthen the LES and prevent stomach acid from flowing back into the esophagus. Common surgical options include Nissen fundoplication, the LINX magnetic device, or Transoral Incisionless Fundoplication (TIF), a minimally i

Chronic acid reflux and heartburn, commonly known as GERD (gastroesophageal reflux disease), can significantly disrupt quality of life, especially when medications and lifestyle adjustments fail to provide relief. At Healthy Life Bariatrics in LA, Dr. Moein-a board-certified surgeon with dual fellowship training in minimally invasive and aesthetic surgery-offers advanced surgical solutions like laparoscopic fundoplication to effectively treat GERD and associated conditions such as hiatal hernia.
Chronic heartburn and acid reflux-formally known as GERD (gastroesophageal reflux disease)-can severely affect daily life, sleep, and esophageal health. At Healthy Life Bariatrics, Dr. Babak Moein now offers surgical solutions for GERD, especially when medications and lifestyle changes aren't enough to control symptoms. His practice in Los Angeles is committed to combining precision, safety, and patient-centered care.

When Is GERD Surgery the Right Choice?

Many patients first try diet changes, weight loss, or proton pump inhibitors to ease their reflux symptoms. But if heartburn persists, or if there is evidence of a hiatal hernia [https://healthylifebariatrics.com/services/hiatal-hernia-surgery-for-relief/] or esophageal damage, surgery may be considered. Dr. Moein evaluates each patient through diagnostic testing and clinical assessment to determine whether surgical intervention is truly needed.

Surgical Approaches & Techniques

Dr. Moein primarily performs laparoscopic fundoplication, which reconstructs and reinforces the lower esophageal sphincter (LES) to prevent acid from flowing backward. In many cases, any concurrent hiatal hernia is repaired during the same operation. These minimally invasive techniques use small incisions, producing less pain, smaller scars, and faster recovery times.

What are the Benefits of General Surgery for GERD?

Those who undergo GERD surgery [https://healthylifebariatrics.com/services/heartburn-gerd-surgery/] typically see:

*
Dramatic reduction or elimination of heartburn, regurgitation, and chest discomfort

*
Very limited dependence on lifelong acid suppression medications

*
Protection against complications such as esophagitis, scar tissue, and Barrett's esophagus

*
Better sleep [https://healthylifebariatrics.com/heartburn-gerd-surgery-for-better-sleep/], improved quality of life, and fewer interruptions by reflux symptoms

Why Patients Choose Dr. Moein for GERD Surgery

Dr. Babak Moein [https://healthylifebariatrics.com/about-us/] offers a specialized blend of surgical expertise in the treatment of gastroesophageal reflux disease (GERD). As a board-certified surgeon with dual fellowship training in minimally invasive surgery and aesthetic body contouring, Dr. Moein approaches reflux surgery with technical precision and a comprehensive understanding of how surgical outcomes impact overall well-being.

His extensive experience in general, bariatric, and laparoscopic procedures enables him to create tailored treatment plans that optimize both function and comfort. At Healthy Life Bariatrics, each GERD surgery is conducted in a fully accredited facility, where patient safety, long-term symptom relief, and quality of life are the primary concerns.

To schedule a consultation or learn more:

Healthy Life Bariatrics

2080 Century Park East, Suite 501

Los Angeles, CA 90067

Phone: +1(310)861-4093

Website: http://healthylifebariatrics.com

Media Contact
Company Name: Healthy Life Bariatrics
Contact Person: Bariatric Surgeon Dr.Moeinolmolki
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lasting-relief-from-acid-reflux-gerd-surgery-in-los-angeles-by-dr-moein]
Phone: +1(310)861-4093
Address:2080 Century Park East, Suite 501
City: Los Angeles
State: CA
Country: United States
Website: https://healthylifebariatrics.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lasting Relief from Acid Reflux: GERD Surgery in Los Angeles by Dr. Moein here

News-ID: 4245528 • Views:

More Releases from ABNewswire

DUB Inhibitors Market to Surpass Multi-Billion-Dollar Milestone by 2040 Across 7MM | 8+ Companies Advancing 10+ Pipeline Therapies in Oncology & Neurodegeneration, analyses DelveInsight
DUB Inhibitors Market to Surpass Multi-Billion-Dollar Milestone by 2040 Across 7 …
DUB Inhibitors Companies are InSilico Medicine, Molecure, KSQ Therapeutics, Roche, Mission Therapeutics, Cothera Bioscience, Asieris Pharmaceuticals, Tango Therapeutics, and others. The DUB inhibitors market is set to witness consistent expansion, fueled by increasing focus on targeted protein degradation and the advancement of innovative oncology therapies. The rising burden of cancer and neurodegenerative conditions is further contributing to market growth. Moreover, the introduction of pipeline candidates such as ISM-3091 by InSilico Medicine,
Ablation Devices Market to Reach USD 15,347.69 Million by 2032, Growing at 8.38% CAGR | Rising Cancer & Cardiac Arrhythmia Cases Drive Demand for Minimally Invasive Technologies, analyses DelveInsight
Ablation Devices Market to Reach USD 15,347.69 Million by 2032, Growing at 8.38% …
Global Ablation Devices Market Forecast 2025-2032 Highlights Strong Growth Momentum Across Oncology, Cardiology, and Pain Management Applications The global Ablation Devices Market is poised for robust expansion, with market size projected to increase from USD 8,090.31 million in 2024 to USD 15,347.69 million by 2032, registering a strong CAGR of 8.38% during the forecast period (2025-2032). The steady growth trajectory reflects rising global demand for minimally invasive treatment modalities, technological innovation
Balloon Valvuloplasty Device Market to Grow at 5.13% CAGR Through 2032, Driven by Rising Cardiovascular Disease Burden and Demand for Minimally Invasive Cardiac Procedures, states DelveInsight
Balloon Valvuloplasty Device Market to Grow at 5.13% CAGR Through 2032, Driven b …
Balloon valvuloplasty device manufacturers include BD, PFM Medical ag, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, and others. The global Balloon Valvuloplasty Device Market is poised for steady expansion, projected to grow at a Compound Annual Growth Rate (CAGR) of 5.13% during the forecast period 2025-2032. Increasing prevalence of cardiovascular diseases (CVDs), rising adoption of minimally invasive cardiac procedures, technological advancements in interventional
Insulin Resistance Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight
Insulin Resistance Pipeline Expands as 20+ Pharma Companies Progress Novel Thera …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2026" report provides comprehensive insights about 20+ companies, including Corbus Pharmaceuticals Holdings, Inc., Kura Oncology, Inc, SCOHIA Pharma Inc, Atrogi, YUNOVIA CO.,LTD., PegBio, Eli Lilly and Company, Tonix Pharma, Pfizer, OrsoBio, Dompe Farmaceutici, GlaxoSmithKline, J. Uriach and Company, Boehringer Ingelheim, Genfit, Novartis, and others, developing 20+ pipeline drugs in the Insulin Resistance pipeline landscape. DelveInsight's "Insulin Resistance - Pipeline Insight, 2026" report provides comprehensive insights

All 5 Releases


More Releases for GERD

GERD Explained: Causes, Symptoms, and Risks
GERD (gastroesophageal reflux disease) happens when the lower esophageal sphincter (LES)-the valve between the stomach and esophagus-doesn't close properly, allowing acid to flow back up. This can cause heartburn, regurgitation, sour taste, chest/throat burning, hoarseness, and trouble swallowing. Over time, ongoing reflux may lead to esophagitis, ulcers, scarring/stricture, and Barrett's esophagus. Understanding GERD: Why Symptoms Persist GERD occurs when the LES does not close properly, allowing stomach acid and digestive contents to
Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal R …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastroesophageal Reflux Disease (GERD) Market Size By 2025? The market encompassing gastroesophageal reflux disease (GERD) has experienced a slight expansion lately, projected to advance from its 2024 valuation of $5.25 billion to $5.33 billion by 2025, reflecting a compound annual growth rate of 1.6%; this
Gastroesophageal Reflux Disease (GERD) Devices Market Insights and Future Outloo …
Introduction Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing symptoms such as heartburn, regurgitation, chest pain, and, in severe cases, esophagitis or Barrett's esophagus. While medications like proton pump inhibitors (PPIs) are widely used for management, a growing number of patients experience refractory GERD, where pharmacological treatments fail to provide relief. This has accelerated demand for GERD devices, which include endoscopic therapies, implantable
Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal R …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Through 2025? The market for gastroesophageal reflux disease (GERD) has seen a slight expansion in recent years. It is projected to increase from $5.25 billion in 2024 to $5.35 billion in 2025, marking a compound annual growth
Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023
WiseGuyReports.Com Publish a New Market Research Report On –“ Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023”. Gerd & Nerd TreatmIndustry 2019 Description:- In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry. The Gastroesophageal Reflux